Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
11.60
-0.27 (-2.27%)
May 21, 2026, 11:00 AM EDT - Market open
Phathom Pharmaceuticals Employees
Phathom Pharmaceuticals had 371 employees as of December 31, 2025. The number of employees decreased by 56 or -13.11% compared to the previous year.
Employees
371
Change (1Y)
-56
Growth (1Y)
-13.11%
Revenue / Employee
$552,270
Profits / Employee
-$423,989
Market Cap
921.39M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 371 | -56 | -13.11% |
| Dec 31, 2024 | 427 | -25 | -5.53% |
| Dec 31, 2023 | 452 | 340 | 303.57% |
| Dec 31, 2022 | 112 | 35 | 45.45% |
| Dec 31, 2021 | 77 | 22 | 40.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MannKind | 592 |
| MeiraGTx Holdings | 409 |
| Pharming Group | 407 |
| Omeros | 175 |
| Sana Biotechnology | 142 |
| Alpha Tau Medical | 121 |
| Cullinan Therapeutics | 109 |
| Janux Therapeutics | 108 |
PHAT News
- 1 day ago - Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting - GlobeNewsWire
- 20 days ago - Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at DDW 2026 Annual Meeting - GlobeNewsWire
- 21 days ago - Phathom Pharmaceuticals reports Q1 non-GAAP EPS (18c), consensus (19c) - TheFly
- 21 days ago - Phathom Pharmaceuticals still sees 2026 revenue $320M-$34M, consensus $332.04M - TheFly
- 21 days ago - Phathom Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 21 days ago - Phathom Pharmaceuticals Earnings release: Q1 2026 - Filings
- 21 days ago - Phathom Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 21 days ago - Phathom Pharmaceuticals Slides: Q1 2026 - Filings